Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeomans

Showing results (641-650 of 1,084) with videos related to

Pageof 109
Sort By:
Gut|April 16, 1999
Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitisC P Tran, G A Cook, N D Yeomans, et al.
Journal of Clinical Pathology|August 1, 1995
Apocrine adenosis: a precursor of aggressive breast cancer?C A Wells, I L McGregor, C N Makunura, et al.
Gene Therapy|February 28, 2014
Gene therapy for trigeminal pain in miceA Z Tzabazis, M Klukinov, D P Feliciano, et al.
British Journal of Cancer|November 1, 1992
Renal size and function after cure of Wilms' tumourG A Levitt, E Yeomans, C Dicks Mireaux, et al.
Annals of the Royal College of Surgeons of England|September 24, 2005
Factors affecting morbidity, mortality and survival in patients undergoing surgery for rectal cancer in a district general hospitalRobert Macadam, Neil Yeomans, Jonathan Wilson, et al.
The European Journal of Neuroscience|March 28, 2008
Joint capsule treatment with enkephalin-encoding HSV-1 recombinant vector reduces inflammatory damage and behavioural sequelae in rat CFA monoarthritisYing Lu, Terry A McNearney, Steven P Wilson, et al.
Journal of Invertebrate Pathology|April 22, 2008
Perkinsus marinus in pleasure oyster Crassostrea corteziensis from Nayarit, Pacific coast of MéxicoJ Cáceres-Martínez, R Vásquez-Yeomans, G Padilla-Lardizábal, et al.
British Journal of Clinical Pharmacology|March 7, 2025
Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspectiveAmy Bobbins, Miranda Davies, Elizabeth Lynn, et al.
North Carolina Medical Journal|April 10, 2015
Traumatic brain injury and behavioral health: the state of treatment and policyJohn Santopietro, Jay A Yeomans, Janet P Niemeier, et al.
Behavior Modification|October 13, 2007
A randomized controlled effectiveness trial of acceptance and commitment therapy and cognitive therapy for anxiety and depressionEvan M Forman, James D Herbert, Ethan Moitra, et al.
Pageof 109

Showing results (641-650 of 1,084) with videos related to

Sort By:
Pageof 109
Gut|April 16, 1999
Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitisC P Tran, G A Cook, N D Yeomans, et al.
Journal of Clinical Pathology|August 1, 1995
Apocrine adenosis: a precursor of aggressive breast cancer?C A Wells, I L McGregor, C N Makunura, et al.
Gene Therapy|February 28, 2014
Gene therapy for trigeminal pain in miceA Z Tzabazis, M Klukinov, D P Feliciano, et al.
British Journal of Cancer|November 1, 1992
Renal size and function after cure of Wilms' tumourG A Levitt, E Yeomans, C Dicks Mireaux, et al.
Annals of the Royal College of Surgeons of England|September 24, 2005
Factors affecting morbidity, mortality and survival in patients undergoing surgery for rectal cancer in a district general hospitalRobert Macadam, Neil Yeomans, Jonathan Wilson, et al.
The European Journal of Neuroscience|March 28, 2008
Joint capsule treatment with enkephalin-encoding HSV-1 recombinant vector reduces inflammatory damage and behavioural sequelae in rat CFA monoarthritisYing Lu, Terry A McNearney, Steven P Wilson, et al.
Journal of Invertebrate Pathology|April 22, 2008
Perkinsus marinus in pleasure oyster Crassostrea corteziensis from Nayarit, Pacific coast of MéxicoJ Cáceres-Martínez, R Vásquez-Yeomans, G Padilla-Lardizábal, et al.
British Journal of Clinical Pharmacology|March 7, 2025
Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspectiveAmy Bobbins, Miranda Davies, Elizabeth Lynn, et al.
North Carolina Medical Journal|April 10, 2015
Traumatic brain injury and behavioral health: the state of treatment and policyJohn Santopietro, Jay A Yeomans, Janet P Niemeier, et al.
Behavior Modification|October 13, 2007
A randomized controlled effectiveness trial of acceptance and commitment therapy and cognitive therapy for anxiety and depressionEvan M Forman, James D Herbert, Ethan Moitra, et al.
Pageof 109